State of Alaska Department of Revenue Purchases 995 Shares of Tabula Rasa HealthCare Inc (TRHC)
State of Alaska Department of Revenue boosted its position in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 22.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,445 shares of the company’s stock after acquiring an additional 995 shares during the period. State of Alaska Department of Revenue’s holdings in Tabula Rasa HealthCare were worth $442,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Comerica Bank bought a new position in Tabula Rasa HealthCare in the second quarter worth approximately $947,000. Citadel Advisors LLC boosted its holdings in Tabula Rasa HealthCare by 47.0% in the second quarter. Citadel Advisors LLC now owns 8,855 shares of the company’s stock worth $565,000 after acquiring an additional 2,832 shares in the last quarter. Pitcairn Co. bought a new position in Tabula Rasa HealthCare in the second quarter worth approximately $285,000. Rhumbline Advisers boosted its holdings in Tabula Rasa HealthCare by 34.5% in the second quarter. Rhumbline Advisers now owns 36,119 shares of the company’s stock worth $2,305,000 after acquiring an additional 9,272 shares in the last quarter. Finally, BlackRock Inc. boosted its holdings in Tabula Rasa HealthCare by 29.7% in the second quarter. BlackRock Inc. now owns 2,119,507 shares of the company’s stock worth $135,288,000 after acquiring an additional 484,979 shares in the last quarter. Institutional investors and hedge funds own 75.29% of the company’s stock.
In other news, CEO Calvin H. Knowlton sold 8,000 shares of the firm’s stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $85.98, for a total value of $687,840.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders sold 48,000 shares of company stock worth $3,630,240 in the last 90 days. Corporate insiders own 14.00% of the company’s stock.
Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Tuesday, August 7th. The company reported $0.20 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.08 by $0.12. Tabula Rasa HealthCare had a positive return on equity of 4.55% and a negative net margin of 16.78%. The company had revenue of $48.60 million for the quarter, compared to analyst estimates of $46.73 million. Equities research analysts anticipate that Tabula Rasa HealthCare Inc will post 0.53 EPS for the current fiscal year.
Several brokerages have issued reports on TRHC. Zacks Investment Research upgraded Tabula Rasa HealthCare from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a report on Saturday, August 11th. Cantor Fitzgerald began coverage on Tabula Rasa HealthCare in a report on Thursday, September 6th. They issued an “overweight” rating and a $99.00 price target on the stock. Citigroup increased their price target on Tabula Rasa HealthCare from $57.00 to $76.00 and gave the stock a “buy” rating in a report on Thursday, August 9th. Robert W. Baird increased their price target on Tabula Rasa HealthCare from $70.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, September 19th. Finally, BidaskClub lowered Tabula Rasa HealthCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 15th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $75.82.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
Featured Story: Dividend Stocks – Are They Right For You?
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.